Xiang-Jing Fu

403 total citations
17 papers, 346 citations indexed

About

Xiang-Jing Fu is a scholar working on Molecular Biology, Organic Chemistry and Rehabilitation. According to data from OpenAlex, Xiang-Jing Fu has authored 17 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 2 papers in Rehabilitation. Recurrent topics in Xiang-Jing Fu's work include Synthesis and biological activity (6 papers), Synthesis and Biological Evaluation (3 papers) and Click Chemistry and Applications (2 papers). Xiang-Jing Fu is often cited by papers focused on Synthesis and biological activity (6 papers), Synthesis and Biological Evaluation (3 papers) and Click Chemistry and Applications (2 papers). Xiang-Jing Fu collaborates with scholars based in China, New Zealand and United States. Xiang-Jing Fu's co-authors include Sai‐Yang Zhang, Jian Song, Shangshang Qin, Xin-Yi Tian, Xiaoting Yan, Jifeng Liu, Yong Guo, Li‐Ping Bai, Cheng‐Yun Jin and Wen‐Bo Liu and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Xiang-Jing Fu

16 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiang-Jing Fu China	10	187	171	43	36	28	17	346
Eman M.E. Dokla Egypt	9	131 0.7×	138 0.8×	16 0.4×	41 1.1×	14 0.5×	22	334
Jenny Johns Australia	8	94 0.5×	187 1.1×	8 0.2×	47 1.3×	9 0.3×	13	432
Xingguang Cai China	14	60 0.3×	296 1.7×	152 3.5×	18 0.5×	5 0.2×	21	456
Ravikumar Akunuri India	10	305 1.6×	224 1.3×	15 0.3×	39 1.1×	32 1.1×	22	455
Yuanwei Dai China	14	270 1.4×	208 1.2×	10 0.2×	27 0.8×	8 0.3×	24	370
Emmanuelle Braud France	13	231 1.2×	280 1.6×	12 0.3×	40 1.1×	69 2.5×	37	473
Lynnie Trzoss United States	12	298 1.6×	264 1.5×	18 0.4×	49 1.4×	12 0.4×	15	697
Kendal Ryter United States	11	124 0.7×	83 0.5×	26 0.6×	11 0.3×	7 0.3×	19	356
Ludovic Landemarre France	12	66 0.4×	168 1.0×	10 0.2×	26 0.7×	3 0.1×	36	373
Chigusa Hayashi Japan	13	183 1.0×	325 1.9×	12 0.3×	28 0.8×	35 1.3×	31	572

Countries citing papers authored by Xiang-Jing Fu

Since Specialization

Citations

This map shows the geographic impact of Xiang-Jing Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang-Jing Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang-Jing Fu more than expected).

Fields of papers citing papers by Xiang-Jing Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang-Jing Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang-Jing Fu. The network helps show where Xiang-Jing Fu may publish in the future.

Co-authorship network of co-authors of Xiang-Jing Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang-Jing Fu. A scholar is included among the top collaborators of Xiang-Jing Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang-Jing Fu. Xiang-Jing Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Na, Yunhe Liu, Ji Yuan Wu, et al.. (2024). Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics. European Journal of Medicinal Chemistry. 276. 116694–116694. 6 indexed citations

Yang, Ruige, Xiang-Jing Fu, Jiangping Fan, et al.. (2024). Semisynthesis and biological evaluation of novel honokiol thioethers against colon cancer cells HCT116 via inhibiting the transcription and expression of YAP protein. Bioorganic & Medicinal Chemistry. 107. 117762–117762. 4 indexed citations

Liu, Xiaojie, et al.. (2024). The RIP3 activator C8 regulates the autophagy flux mediated by p62 and promotes the immunogenic form of cell death in human gastric cancer cells. Bioorganic Chemistry. 153. 107937–107937. 1 indexed citations

Fu, Xiang-Jing, Na Li, Ziyue Wang, et al.. (2024). Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance. European Journal of Medicinal Chemistry. 277. 116761–116761. 3 indexed citations

Song, Jian, Shuyu Wang, Xiao Wang, et al.. (2023). Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities. Bioorganic Chemistry. 137. 106580–106580. 12 indexed citations

Liu, Xiaojie, Lu Liu, Xu Wang, et al.. (2023). Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer. Phytomedicine. 118. 154943–154943. 24 indexed citations

Liu, Xiujuan, Xiao Wang, Wang Wang, et al.. (2023). Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers. European Journal of Medicinal Chemistry. 252. 115281–115281. 20 indexed citations

Shi, Xiaoyi, Jiao Huang, Jiakai Zhang, et al.. (2023). Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2237701–2237701. 6 indexed citations

Fu, Xiang-Jing, Jiao Huang, Na Li, et al.. (2023). Design, synthesis and biological evaluation of N-benzylaryl cinnamide derivatives as tubulin polymerization inhibitors capable of promoting YAP degradation with potent anti-gastric cancer activities. European Journal of Medicinal Chemistry. 262. 115883–115883. 8 indexed citations

10.

Liu, Fangfang, Wenbo Liu, Yifan Zhang, et al.. (2022). A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo. Biochemical Pharmacology. 201. 115070–115070. 20 indexed citations

11.

Song, Jian, Wen‐Bo Liu, Xin-Yi Tian, et al.. (2022). Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities. European Journal of Medicinal Chemistry. 238. 114467–114467. 43 indexed citations

12.

Song, Jian, Shenghui Wang, Weixin Zhang, et al.. (2022). Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway. European Journal of Medicinal Chemistry. 240. 114583–114583. 27 indexed citations

13.

Song, Jian, Ting Zhu, Xin-Yi Tian, et al.. (2022). Discovery of Novel Coumarin-Indole Derivatives As Tubulin Polymerization Inhibitors with Potent Anti-Gastric Cancer Activities. SSRN Electronic Journal.

14.

Guo, Yong, Xiaoting Yan, Li‐Ping Bai, et al.. (2021). Development of Membrane-Active Honokiol/Magnolol Amphiphiles as Potent Antibacterial Agents against Methicillin-Resistant Staphylococcus aureus (MRSA). Journal of Medicinal Chemistry. 64(17). 12903–12916. 97 indexed citations

15.

Song, Jian, Yuan Liu, Wenbo Liu, et al.. (2021). Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers. European Journal of Medicinal Chemistry. 225. 113801–113801. 19 indexed citations

16.

Hou, Lin, Chunyu Tian, Qian‐Xiao Huang, et al.. (2020). Single-dose in situ storage for intensifying anticancer efficacy via combinatorial strategy. Journal of Controlled Release. 319. 438–449. 16 indexed citations

17.

Yang, Yi, et al.. (2019). Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity. ACS Infectious Diseases. 5(9). 1535–1545. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact